In some epidemiologic studies, the shorter FokI VDR allelic variation has been associated with a host of adverse disease outcomes (16, 17), including increased risk to MetS in adults (2, 3, 15, 16, 18, 19). This evidence concerns the gene VDR and metabolic syndrome.